NR4A1 and breast cancer: Therefore, pooling of BC secretome datasets provides an integrated, bioinformatic approach for decreasing individual study bias and highlighting BC biomarkers that extend beyond cell line specific hormonal receptor status, thereby having a broader clinical applicability.